Hyperfine (HYPR) Share-based Compensation (2021 - 2026)
Hyperfine (HYPR) posted Share-based Compensation of $647000.0 for Q1 2026, down 6.5% on a QoQ basis from $692000.0 in Q4 2025, and down 31.53% year-over-year from $945000.0 in Q1 2025.
Hyperfine (HYPR) Share-based Compensation (2021 - 2026) Analysis & Trends
Hyperfine's Share-based Compensation history runs 6 years deep, the most recent figure standing at $647000.0 for Q1 2026.
- Quarterly Share-based Compensation fell 31.53% year-over-year to $647000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 41.45% YoY) and the FY2025 annual result came in at $2.8 million, down 56.82% from the prior year.
- Share-based Compensation was $647000.0 for Q1 2026 at Hyperfine, down from $692000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.1 million in Q2 2022 and bottomed at -$2.4 million in Q3 2022.
- A 5-year average of $1.4 million and a median of $1.1 million in 2024 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 1439.7% in 2022, while the deepest fall reached 271.2% in 2022.
- Hyperfine's Share-based Compensation stood at $1.8 million in 2022, then fell by 28.17% to $1.3 million in 2023, then retreated by 18.17% to $1.1 million in 2024, then slumped by 34.35% to $692000.0 in 2025, then dropped by 6.5% to $647000.0 in 2026.
- Business Quant data shows HYPR's Share-based Compensation at $647000.0 in Q1 2026, $692000.0 in Q4 2025, and $617000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 647,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 647,000.00 |
| Mar 31, 2026 | 647,000.00 |
| Dec 31, 2025 | 692,000.00 |
| Dec 31, 2025 | 692,000.00 |
| Sep 30, 2025 | 617,000.00 |
| Sep 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 547,000.00 |
| Jun 30, 2025 | 547,000.00 |
| Mar 31, 2025 | 945,000.00 |
| Mar 31, 2025 | 945,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Dec 31, 2023 | 1.29 Mn |